140 related articles for article (PubMed ID: 20212335)
1. The effect of point mutations in dihydrofolate reductase genes and multidrug resistance gene 1-86 on treatment of falciparum malaria in Sudan.
Yusuf RU; Omar SA; Ngure RM
J Infect Dev Ctries; 2010 Mar; 4(2):61-9. PubMed ID: 20212335
[TBL] [Abstract][Full Text] [Related]
2. Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations.
Hamour S; Melaku Y; Keus K; Wambugu J; Atkin S; Montgomery J; Ford N; Hook C; Checchi F
Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):548-54. PubMed ID: 15869770
[TBL] [Abstract][Full Text] [Related]
3. A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern India.
Srivastava P; Ratha J; Shah NK; Mishra N; Anvikar AR; Sharma SK; Das MK; Srivastava B; Valecha N
Malar J; 2013 Jul; 12():247. PubMed ID: 23866298
[TBL] [Abstract][Full Text] [Related]
4. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré.
Bonnet M; Roper C; Félix M; Coulibaly L; Kankolongo GM; Guthmann JP
Malar J; 2007 May; 6():54. PubMed ID: 17477865
[TBL] [Abstract][Full Text] [Related]
6. High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.
Adeel AA; Elnour FA; Elmardi KA; Abd-Elmajid MB; Elhelo MM; Ali MS; Adam MA; Atta H; Zamani G; Warsame M; Barrette A; Mohammady HE; Nada RA
Malar J; 2016 May; 15(1):285. PubMed ID: 27209063
[TBL] [Abstract][Full Text] [Related]
7. dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo.
Alker AP; Kazadi WM; Kutelemeni AK; Bloland PB; Tshefu AK; Meshnick SR
Trop Med Int Health; 2008 Nov; 13(11):1384-91. PubMed ID: 19055622
[TBL] [Abstract][Full Text] [Related]
8. Prevailing Plasmodium falciparum dihydrofolate reductase 108-asparagine in Hodeidah, Yemen: a questionable sulfadoxine-pyrimethamine partner within the artemisinin-based combination therapy.
Abdul-Ghani R; Farag HF; Allam AF; Shawky SM
Acta Trop; 2014 Apr; 132():39-44. PubMed ID: 24406851
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Tahar R; Basco LK
Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
Bwijo B; Kaneko A; Takechi M; Zungu IL; Moriyama Y; Lum JK; Tsukahara T; Mita T; Takahashi N; Bergqvist Y; Björkman A; Kobayakawa T
Acta Trop; 2003 Mar; 85(3):363-73. PubMed ID: 12659974
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
Durrani N; Leslie T; Rahim S; Graham K; Ahmad F; Rowland M
Trop Med Int Health; 2005 Jun; 10(6):521-9. PubMed ID: 15941414
[TBL] [Abstract][Full Text] [Related]
13. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
Kayentao K; Maiga H; Newman RD; McMorrow ML; Hoppe A; Yattara O; Traore H; Kone Y; Guirou EA; Saye R; Traore B; Djimde A; Doumbo OK
Malar J; 2009 Jan; 8():5. PubMed ID: 19128455
[TBL] [Abstract][Full Text] [Related]
14. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
[TBL] [Abstract][Full Text] [Related]
15. The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination.
Malisa AL; Pearce RJ; Mutayoba BM; Abdullah S; Mshinda H; Kachur PS; Bloland P; Roper C
Malar J; 2011 Oct; 10():317. PubMed ID: 22029848
[TBL] [Abstract][Full Text] [Related]
16. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
Biswas S
J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993
[TBL] [Abstract][Full Text] [Related]
17. Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles.
Warsame M; Hassan AM; Barrette A; Jibril AM; Elmi HH; Arale AM; Mohammady HE; Nada RA; Amran JG; Muse A; Yusuf FE; Omar AS
Trop Med Int Health; 2015 Apr; 20(4):510-7. PubMed ID: 25583123
[TBL] [Abstract][Full Text] [Related]
18. Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Ibrahium AM; Kheir MM; Osman ME; Khalil IF; Alifrangis M; Elmardi KA; Malik EM; Adam I
Ann Trop Med Parasitol; 2007 Jan; 101(1):15-21. PubMed ID: 17244406
[TBL] [Abstract][Full Text] [Related]
19. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
[TBL] [Abstract][Full Text] [Related]
20. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH
Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
